Mettler-Toledo International (NYSE:MTD) Releases FY 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 47.150-47.500 for the period, compared to the consensus EPS estimate of 46.640. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q3 2026 guidance to 12.000-12.150 EPS.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $9.63 during trading on Thursday, reaching $1,378.70. The stock had a trading volume of 203,522 shares, compared to its average volume of 152,613. The company has a market cap of $27.86 billion, a P/E ratio of 32.33, a PEG ratio of 2.90 and a beta of 1.24. Mettler-Toledo International has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The business’s 50-day moving average price is $1,231.02 and its 200-day moving average price is $1,275.04.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.80 by $0.66. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same quarter in the prior year, the company earned $10.09 EPS. Mettler-Toledo International’s revenue was up 4.5% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. Analysts forecast that Mettler-Toledo International will post 46.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on MTD shares. Citigroup reduced their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Stifel Nicolaus dropped their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Robert W. Baird cut their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Barclays reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Finally, Morgan Stanley dropped their price target on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 12th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,408.55.

Institutional Trading of Mettler-Toledo International

A number of institutional investors have recently bought and sold shares of the business. Douglass Winthrop Advisors LLC boosted its position in shares of Mettler-Toledo International by 4,990.0% during the 4th quarter. Douglass Winthrop Advisors LLC now owns 48,253 shares of the medical instruments supplier’s stock worth $67,274,000 after acquiring an additional 47,305 shares in the last quarter. Bank of America Corp DE lifted its stake in Mettler-Toledo International by 56.8% during the third quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock worth $157,276,000 after purchasing an additional 46,402 shares during the last quarter. Invesco Ltd. lifted its stake in Mettler-Toledo International by 24.5% during the fourth quarter. Invesco Ltd. now owns 235,342 shares of the medical instruments supplier’s stock worth $328,111,000 after purchasing an additional 46,342 shares during the last quarter. Holocene Advisors LP boosted its holdings in Mettler-Toledo International by 320.2% in the second quarter. Holocene Advisors LP now owns 56,439 shares of the medical instruments supplier’s stock valued at $66,300,000 after purchasing an additional 43,007 shares in the last quarter. Finally, Select Equity Group L.P. acquired a new position in Mettler-Toledo International in the second quarter valued at approximately $46,332,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.